Viewing Study NCT01750216


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2026-02-25 @ 8:59 PM
Study NCT ID: NCT01750216
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-07
Start Date Type: None
Primary Completion Date: 2015-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01
Completion Date Type: ACTUAL
First Submit Date: 2012-12-12
First Submit QC Date: None
Study First Post Date: 2012-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-01
Last Update Post Date: 2016-11-02
Last Update Post Date Type: ESTIMATED